English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 30 November 2020, 14:00 HKT/SGT
Share:
    

Source: China Shineway Pharmaceutical Group Limited
Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

HONG KONG, Nov 30, 2020 - (ACN Newswire) - Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.


Topic: Press release summary
Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Shineway Pharmaceutical Group Limited Releated News
Dec 1, 2020 04:40 HKT/SGT
China Shineway Pharmaceutical records 29.4% revenue growth in October
Nov 30, 2020 14:00 HKT/SGT
神威藥業 (02877.HK) 十月份單月營業額比去年同期錄得29.4%增長
Nov 30, 2020 14:00 HKT/SGT
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长
More news >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575